(Q44374765)

2 December 2017

title

A systemically administered neurotensin agonist blocks disruption of prepulse inhibition produced by a serotonin-2A agonist (English)

1 reference

2 December 2017

0 references

David Feifel

1

1 reference

2 December 2017

Gilia Melendez

series ordinal

2

1 reference

2 December 2017

Paul D Shilling

series ordinal

3

1 reference

2 December 2017

language of work or name

English

0 references

publication date

10 October 2002

1 reference

2 December 2017

published in

Neuropsychopharmacology

1 reference

2 December 2017

volume

28

1 reference

2 December 2017

issue

4

1 reference

2 December 2017

page(s)

651-653

1 reference

Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300083

Stimulation by neurotensin of (3H)5-hydroxytryptamine (5HT) release from rat frontal cortex slices

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300083

Neurotensin: an endogenous antipsychotic?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300083

The role of serotonin in antipsychotic drug action

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300083

DOI disrupts prepulse inhibition of startle in rats via 5-HT2A receptors in the ventral pallidum

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300083

21 January 2018

Identifiers

DOI

10.1038/SJ.NPP.1300083

1 reference

2 December 2017

1 reference